Ruilin Quan
Chinese Academy of Medical Sciences & Peking Union Medical College(CN)Fu Wai Hospital(CN)
Publications by Year
Research Areas
Pulmonary Hypertension Research and Treatments, Cardiovascular Function and Risk Factors, Heart Failure Treatment and Management, Cardiovascular Issues in Pregnancy, Congenital Heart Disease Studies
Most-Cited Works
- → Supplementation with Iron in Pulmonary Arterial Hypertension. Two Randomized Crossover Trials(2021)51 cited
- → Characteristics, goal‐oriented treatments and survival of pulmonary arterial hypertension in China: Insights from a national multicentre prospective registry(2022)41 cited
- → Characteristics and long‐term survival of patients with chronic thromboembolic pulmonary hypertension in China(2020)31 cited
- → Balloon pulmonary angioplasty reverse right ventricular remodelling and dysfunction in patients with inoperable chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis(2020)30 cited
- → Nestin represents a potential marker of pulmonary vascular remodeling in pulmonary arterial hypertension associated with congenital heart disease(2020)21 cited
- → 10-year survival of pulmonary arterial hypertension associated with connective tissue disease: insights from a multicentre PAH registry(2023)20 cited
- → Characteristics, Long-term Survival, and Risk Assessment of Pediatric Pulmonary Arterial Hypertension in China(2022)18 cited
- → The value of three-dimensional echocardiography in risk stratification in pulmonary arterial hypertension: a cross-sectional study(2019)13 cited
- → The prevalence and survival of pulmonary hypertension due to left heart failure: A retrospective analysis of a multicenter prospective cohort study(2022)13 cited
- → Characteristics, treatments and survival of pulmonary arterial hypertension associated with congenital heart disease in China: Insights from a national multicenter prospective registry(2023)11 cited